| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/1997 | EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 07/23/1997 | EP0784684A2 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/23/1997 | EP0784681A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 07/23/1997 | EP0784680A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 07/23/1997 | EP0784679A1 Cancer treatment by expression of differentiation factor receptor |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784676A1 Neutralization of foof allergens by thioredoxin |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
| 07/23/1997 | EP0784633A1 Process for purifying factor viii |
| 07/23/1997 | EP0784632A1 Process for extracting high-purity von willebrand factor |
| 07/23/1997 | EP0784630A1 Selective inhibition of internally initiated rna translation |
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 07/23/1997 | EP0784628A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 07/23/1997 | EP0784489A2 Composition use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/23/1997 | EP0784488A1 Use of neuregulins as modulators of cellular communication |
| 07/23/1997 | EP0784486A1 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 07/23/1997 | EP0784485A1 Vaccine compositions |
| 07/23/1997 | EP0784484A2 Method of treatment of human immunodeficiency virus (hiv) infection |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784482A2 Methods for inhibiting antigen specific t cell responses |
| 07/23/1997 | EP0784481A1 Wound healing formulations containing human plasma fibronectin |
| 07/23/1997 | EP0784480A1 Use of erythropoietin in the treatment of rheumatoid arthritis |
| 07/23/1997 | EP0784479A1 Inhibition of human rotavirus infection |
| 07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 07/23/1997 | EP0784477A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 07/23/1997 | EP0784472A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 07/23/1997 | EP0784471A2 Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| 07/23/1997 | EP0784469A1 Compositions for the delivery of antigens |
| 07/23/1997 | EP0784429A1 Method and formulation of stimulating nitric oxide synthesis |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0643772B1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/23/1997 | EP0641236B1 A method for coated particles in a spray-drying plant |
| 07/23/1997 | EP0554400B1 Retroviral protease inhibitors |
| 07/23/1997 | EP0531341B1 Use of leukoregulin for the treatment of animals infected with an envelope-virus |
| 07/23/1997 | EP0502968B1 Activatable fibrinolytic and anti-thrombotic proteins |
| 07/23/1997 | EP0477386B1 Pharmaceutical aerosol formulation of solid polypeptide microparticles and method for the preparation thereof |
| 07/23/1997 | EP0474846B1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/23/1997 | CN1155248A Somatostatin binding peptide-metal chelate conjugates |
| 07/23/1997 | CN1155246A CCK antibodies used to improve feed efficiency |
| 07/23/1997 | CN1155245A Use of muramyl peptide compounds |
| 07/23/1997 | CN1154971A Thrombopoietin and prepn. method and usage thereof |
| 07/23/1997 | CN1154970A Antibiotic peptide and production method and application thereof |
| 07/23/1997 | CN1154851A Blood-enriching agent-Yixuejing and preparation method thereof |
| 07/22/1997 | US5650538 Organic salts of N,N'-diacetyl cystine |
| 07/22/1997 | US5650508 Inhibitors of serine and cysteine proteases |
| 07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
| 07/22/1997 | US5650502 Ribozyme analogs having rigid non-nucleotidic linkers |
| 07/22/1997 | US5650495 Protein having an affinity for a heparin-binding growth factor |
| 07/22/1997 | US5650494 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/22/1997 | US5650492 P-40 homodimer of interleukin-12 |
| 07/22/1997 | US5650491 BCL-2-associated proteins |
| 07/22/1997 | US5650490 Tie-2 ligand 2 |
| 07/22/1997 | US5650489 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 07/22/1997 | US5650488 Polypeptide inhibitor of the replication of HSV |
| 07/22/1997 | US5650487 Blood disorders |
| 07/22/1997 | US5650486 Monomeric insulin analog formulations |
| 07/22/1997 | US5650447 Nitric oxide-releasing polymers to treat restenosis and related disorders |
| 07/22/1997 | US5650442 Use of nitric oxide releasing compounds as hypoxic cell radiation sensitizers |
| 07/22/1997 | US5650435 Modulation of inflammation related to columnar epithelia |
| 07/22/1997 | US5650408 Thiazolo benzazepine containing dual action inhibitors |
| 07/22/1997 | US5650398 Drug delivery enhancement via modified saponins |
| 07/22/1997 | US5650396 Methods of modulating inflammatory cytokines in the CNS using TGF-β |
| 07/22/1997 | US5650395 Treatment of pulmonary hypertension |
| 07/22/1997 | US5650394 Use of urinastatin-like compounds to prevent premature delivery |
| 07/22/1997 | US5650392 Method and composition for the treatment of septic shock |
| 07/22/1997 | US5650391 Methods and compositions for inhibition of hepatic clearance of tissue factor pathway inhibitor |
| 07/22/1997 | US5650390 Glycine |
| 07/22/1997 | US5650389 Administering decorin to suppress antibody dependent complement activation |
| 07/22/1997 | US5650388 Fractionated polyalkylene oxide-conjugated hemoglobin solutions |
| 07/22/1997 | US5650386 Compositions for oral delivery of active agents |
| 07/22/1997 | US5650319 Viricides and antibodies |
| 07/22/1997 | US5650316 Uses of triplex forming oligonucleotides for the treatment of human diseases |
| 07/22/1997 | US5650314 Recombinant agents affection thrombosis |
| 07/22/1997 | US5650313 Ubiquitin conjugating enzymes 8 and 9 |
| 07/22/1997 | US5650309 Viral vectors |
| 07/22/1997 | US5650306 Genetic engineering with gene expression for controlling sequences |
| 07/22/1997 | US5650301 Hirudin HV2 having a SN7LYS substitution, method of making, and method of use |
| 07/22/1997 | US5650300 Method of producing monoclonal antibodies to oncofetal protein |
| 07/22/1997 | US5650299 Cells producing stem cell proliferation factor |
| 07/22/1997 | US5650297 Gene expression, escherichia |
| 07/22/1997 | US5650295 Polynucleotides and polypeptides for genetic engineering |
| 07/22/1997 | US5650293 Nucleic acid encoding pp60PIK and the methods of making pp60PIK |
| 07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 07/22/1997 | US5650291 Monoclonal antibodies against an antigen associated with ovarian cervical and other tumors |
| 07/22/1997 | US5650285 Human CRIPTO-related gene and method of measuring CR-3 |
| 07/22/1997 | US5650280 Cellubrevin homolog |
| 07/22/1997 | US5650276 Morphogenic protein screening method |
| 07/22/1997 | US5650154 Protective antigens against disease pathogens |
| 07/22/1997 | US5650152 Vaccines for antitumor agents |
| 07/22/1997 | US5650150 Recombinant antibody cytokine fusion proteins |
| 07/22/1997 | US5650148 Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/22/1997 | US5650147 Administering a cytokine |
| 07/22/1997 | US5650137 Cosmetic composition containing a superoxide dismutase and a porphyrin |
| 07/22/1997 | US5649904 Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both |
| 07/19/1997 | CA2195051A1 Amylase inhibitors |
| 07/18/1997 | CA2195371A1 Immunosuppressive-activity potentiating compositions |
| 07/17/1997 | WO1997025620A1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |